122 related articles for article (PubMed ID: 27930628)
21. Physical activity programmes for patients undergoing neo-adjuvant chemoradiotherapy for rectal cancer: A systematic review and meta-analysis.
Latrille M; Buchs NC; Ris F; Koessler T
Medicine (Baltimore); 2021 Dec; 100(51):e27754. PubMed ID: 34941028
[TBL] [Abstract][Full Text] [Related]
22. A Randomized Phase 2 Study of Neoadjuvant Chemoradiaton Therapy With 5-Fluorouracil/Leucovorin or Irinotecan/S-1 in Patients With Locally Advanced Rectal Cancer.
Jung M; Shin SJ; Koom WS; Jung I; Keum KC; Hur H; Min BS; Baik SH; Kim NK; Kim H; Lim JS; Hong SP; Kim TI; Roh JK; Park YS; Ahn JB
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1015-22. PubMed ID: 26581140
[TBL] [Abstract][Full Text] [Related]
23. In favor of total neoadjuvant therapy (TNT) for locally advanced rectal carcinoma.
Arias F; Asín G; Flamarique S; Hernández I; Suarez J
Clin Transl Oncol; 2020 May; 22(5):793-794. PubMed ID: 31309436
[No Abstract] [Full Text] [Related]
24. Evidence-based routine use vs selective use of neoadjuvant therapy in practice: toward personalized management of advanced rectal cancer.
Penninckx F
Colorectal Dis; 2012 Jul; 14(7):795-6. PubMed ID: 22681229
[No Abstract] [Full Text] [Related]
25. Diversion with neoadjuvant vs surgery with adjuvant treatment for obstructing rectal cancer?
Kaiser AM
Dis Colon Rectum; 2012 Oct; 55(10):e346. PubMed ID: 22965410
[No Abstract] [Full Text] [Related]
26. Watch and wait for rectal cancer: where are we really at?
Smith FM; Winter D
Colorectal Dis; 2014 May; 16(5):332-4. PubMed ID: 24725661
[No Abstract] [Full Text] [Related]
27. [Decrease of the number of involved lymph nodes after preoperative chemoradiotherapy in rectal carcinoma].
Rasulov AO; Shelygin IuA; Rybakov EG; Boĭko AV; Droshneva IV
Vopr Onkol; 2012; 58(4):493-7. PubMed ID: 23607203
[TBL] [Abstract][Full Text] [Related]
28. The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Daniel ES; Gibbs P; Guerrieri M; Faragher I
Colorectal Dis; 2014 Oct; 16(10):783-7. PubMed ID: 24786681
[TBL] [Abstract][Full Text] [Related]
29. Combined modality therapy for rectal cancer: too much too often?
Weiser MR
Ann Surg Oncol; 2013 Jun; 20(6):1753-5. PubMed ID: 23508584
[No Abstract] [Full Text] [Related]
30. Opinions have changed on the management of rectal cancer with a complete clinical response to neoadjuvant chemoradiotherapy.
São Julião GP; Smith FM; Macklin CP; George ML; Wynn GR
Colorectal Dis; 2014 May; 16(5):392-4. PubMed ID: 24612274
[No Abstract] [Full Text] [Related]
31. Predictors of Long-Term Quality of Life for Survivors of Stage II/III Rectal Cancer in the Cancer Care Outcomes Research and Surveillance Consortium.
Charlton ME; Stitzenberg KB; Lin C; Schlichting JA; Halfdanarson TR; Juarez GY; Pendergast JF; Chrischilles EA; Wallace RB
J Oncol Pract; 2015 Jul; 11(4):e476-86. PubMed ID: 26080831
[TBL] [Abstract][Full Text] [Related]
32. Should We Give Up The Search for a Clinically Useful Gene Signature for the Prediction of Response of Rectal Cancer to Neoadjuvant Chemoradiation?
Perez RO; Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Camargo AA
Dis Colon Rectum; 2016 Sep; 59(9):895-7. PubMed ID: 27505119
[No Abstract] [Full Text] [Related]
33. Is diffusion-weighted MRI superior to FDG-PET or FDG-PET/CT in evaluating and predicting pathological response to preoperative neoadjuvant therapy in patients with rectal cancer?
Li YL; Wu LM; Chen XX; Delproposto Z; Hu JN; Xu JR
J Dig Dis; 2014 Oct; 15(10):525-37. PubMed ID: 25060294
[TBL] [Abstract][Full Text] [Related]
34. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy?
Kiran RP; Kirat HT; Burgess AN; Nisar PJ; Kalady MF; Lavery IC
Ann Surg Oncol; 2012 Apr; 19(4):1206-12. PubMed ID: 21935748
[TBL] [Abstract][Full Text] [Related]
35. [Current principles and approaches to the treatment for patients with locally advanced rectal cancer].
Aliev II; Guliaev AV; Pravosudov IV; Karachun AM
Vopr Onkol; 2012; 58(2):203-6. PubMed ID: 22774525
[TBL] [Abstract][Full Text] [Related]
36. Is it time for a rethink of the management of patients with rectal cancer?
Hemingway D
Colorectal Dis; 2015 Aug; 17(8):736. PubMed ID: 25990551
[No Abstract] [Full Text] [Related]
37. [Choosing combined or complex treatment approach in oral SCC patients].
Matiakin EG; Iakovleva LP; Romanov IS; Pavlovskaia AI; Tsiklauri VT; Dzhumaev MG
Stomatologiia (Mosk); 2012; 91(5):28-30. PubMed ID: 23268181
[TBL] [Abstract][Full Text] [Related]
38. Adjuvant chemotherapy following neoadjuvant therapy of rectal cancer: the type of neoadjuvant therapy (chemoradiotherapy or radiotherapy) may be important for selection of patients.
Fietkau R; Klautke G
J Clin Oncol; 2008 Jan; 26(3):507-8; author reply 508-9. PubMed ID: 18202428
[No Abstract] [Full Text] [Related]
39. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
[TBL] [Abstract][Full Text] [Related]
40. [Neoadjuvant chemoradiation therapy for locally advanced rectal cancer].
Sato T; Ozawa H; Kisyu K; Kumamoto H; Nakamura T; Onozato W; Yamanashi T; Kokuba Y; Ihara A; Watanabe M
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1553-6. PubMed ID: 17940371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
